Biotech company Debut secures Series B funding through L’Oreal venture capital fund BOLD
This month, biotech company Debut secured $34 million in Series B funding from a group of vested participants including BOLD, L’Oreal’s venture capital fund. Through the strategic partnership with BOLD,…